Results 21 to 26 of about 28 (26)

The malaria-infected red blood cell: structural and functional changes. [PDF]

Adv Parasitol, 2001
Cooke BM, Mohandas N, Coppel RL.
europepmc   +1 more source

Global mutational analysis of NtrC-like activators in Myxococcus xanthus: identifying activator mutants defective for motility and fruiting body development. [PDF]

J Bacteriol, 2003
Caberoy NB, Welch RD, Jakobsen JS, Slater SC, Garza AG.   +4 more
europepmc   +1 more source

Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. [PDF]

Proc Natl Acad Sci U S A, 1996
Baruch DI, Gormely JA, Ma C, Howard RJ, Pasloske BL.   +4 more
europepmc   +1 more source

Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11.1 gene product. [PDF]

J Exp Med, 1993
Feng Z, Hoffmann RN, Nussenzweig RS, Tsuji M, Fujioka H, Aikawa M, Lensen TH, Ponnudurai T, Pologe LG.   +8 more
europepmc   +1 more source

Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. [PDF]

Genetics, 1998
Escalante AA, Lal AA, Ayala FJ.
europepmc   +1 more source

Epitope specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332

Parasite Immunology, 1993
SummaryIt has earlier been shown that the Plasmodium falciparum‐reactive human monoclonal antibody 33G2 inhibits parasite growth in vitro as well as cytoadherence of infected red blood cells to melanoma cells in vitro. MoAb 33G2 recognizes an epitope of the P.
N, Ahlborg, B W, Flyg, J, Iqbal, P, Perlmann, K, Berzins   +4 more
openaire   +2 more sources